Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...

Pharmacokinetics in Pediatric Patients: Drug Excretion

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Practical recommendations for treating patients with chronic kidney disease in Australia: a multidisciplinary approach.

Internal medicine journal·2026

Same author

Motor skill competence and moderate- and vigorous-intensity physical activity: a linear and non-linear cross-sectional analysis of eight pooled trials.

The international journal of behavioral nutrition and physical activity·2024

Same author

A peer coach intervention in childcare centres enhances early childhood physical activity: The Active Early Learning (AEL) cluster randomised controlled trial.

The international journal of behavioral nutrition and physical activity·2021

Same author

Urea: another analyte recommended for harmonised reference intervals.

Pathology·2018

Same author

'Aussie Normals': an a priori study to develop reference intervals in a healthy Australian population using the Beckman Coulter LH 750 Haematology Analyser as candidates for harmonised values.

Pathology·2017

Same author

Does physical education influence eye-hand coordination? The Lifestyles of our Kids intervention study.

Scandinavian journal of medicine & science in sports·2016

Search research articles

Related Experiment Video

Updated: May 22, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

NTproBNP concentrations in healthy children.

G Koerbin¹, W P Abhayaratna, J M Potter

¹ACT Pathology, Canberra, Australia. gus.koerbin@act.gov.au

Clinical Biochemistry

|May 22, 2012

Summary

N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in healthy children aged 8 to 12 years were assessed. NT-proBNP concentrations progressively decline with age in this pediatric group.

More Related Videos

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Related Experiment Videos

Last Updated: May 22, 2026

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

A Convenient Method for Extraction and Analysis with High-Pressure Liquid Chromatography of Catecholamine Neurotransmitters and Their Metabolites

Published on: March 1, 2018

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

How to Administer Near-Infrared Spectroscopy in Critically ill Neonates, Infants, and Children

Published on: August 19, 2020

Area of Science:

Pediatric cardiology
Biomarker research
Clinical diagnostics

Background:

Limited reference intervals exist for BNP and NT-proBNP in pediatric populations.
The Lifestyle of Our Kids (LOOK) study enrolled 854 healthy children.

Purpose of the Study:

To prospectively assess NT-proBNP levels in healthy school-aged children.
To establish age- and gender-specific reference intervals for NT-proBNP.

Main Methods:

NT-proBNP analysis was conducted on 854 healthy children aged 8.1, 10.1, and 11.9 years.
Data were stratified by age and gender, calculating median, range, and 2.5th/97.5th percentiles.

Main Results:

No significant gender differences in NT-proBNP levels were observed at any age.
Significant age-related differences were noted, particularly between younger and older children.

Conclusions:

NT-proBNP concentrations progressively decline in healthy children between ages 8 and 12 years.
This study's findings of lower 97.5th percentile NT-proBNP concentrations suggest stricter health criteria for participants.